Danvatirsen

For research use only. Not for therapeutic Use.

  • CAT Number: I043997
  • CAS Number: 1402357-06-5
  • Molecular Weight: 5422.00
  • Purity: ≥95%
Inquiry Now

Danvatirsen(Cat No.:I043997)is an investigational antisense oligonucleotide designed to target and inhibit the expression of specific genes involved in cancer progression. By binding to messenger RNA (mRNA), Danvatirsen prevents the translation of the targeted protein, which may play a role in tumor growth and survival. It has shown promise in clinical studies for its potential use in treating various cancers, including non-small cell lung cancer (NSCLC). As part of targeted therapy, Danvatirsen aims to improve treatment outcomes by disrupting critical molecular pathways involved in cancer cell proliferation and metastasis.

Request a Quote